SCHEMBL20171027

SCHEMBL20171027

C/N=C/c1ccc(S(=O)(=O)NC)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.53
GAA P10253 1/20 0.53
CA12 O43570 2/20 0.52
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
CA3 P07451 2/20 0.52
CA4 P22748 2/20 0.52
CA6 P23280 2/20 0.52
CA5A P35218 2/20 0.52
CA7 P43166 2/20 0.52
CA9 Q16790 2/20 0.52
CA13 Q8N1Q1 2/20 0.52
CA14 Q9ULX7 2/20 0.52
CA5B Q9Y2D0 2/20 0.52
LMNA P02545 2/20 0.50
HTT P42858 1/20 0.50
ALDH1A1 P00352 5/20 0.48
NR3C2 P08235 1/20 0.43
KMT2A Q03164 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13232812 0.84 ALDH1A1 (0.53) SMN1; SMN2GAACA12CA1CA2
SCHEMBL13232817 0.83 GAA (0.52) SMN1; SMN2GAACA12CA1CA2
SCHEMBL8759183 0.80 ALDH1A1 (0.61) SMN1; SMN2GAACA12CA1CA2
SCHEMBL8759188 0.80 ALDH1A1 (0.61) SMN1; SMN2GAACA12CA1CA2
SCHEMBL7629070 0.78 SMN1; SMN2 (0.80) SMN1; SMN2GAACA12CA1CA2
SCHEMBL849326 0.78 SMN1; SMN2 (0.59) SMN1; SMN2GAACA12CA1CA2
SCHEMBL21129231 0.78 ALDH1A1 (0.53) CA1CA2CA7CA9ALDH1A1
SCHEMBL1494528 0.76 SMN1; SMN2 (0.57) SMN1; SMN2GAACA12CA1CA2
SCHEMBL22389454 0.73 SMN1; SMN2 (0.48) SMN1; SMN2GAALMNAALDH1A1KMT2A
SCHEMBL8080277 0.72 SMN1; SMN2 (0.70) SMN1; SMN2GAACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2772480-B2 HIV REPLICATION INHIBITOR SHIONOGI & CO (JP) 2020-12-09 EP disclosed
EP-2772480-B1 HIV REPLICATION INHIBITOR SHIONOGI & CO (JP) 2018-05-23 EP disclosed